Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Microsoft PowerPoint - ACCC Reim Coding for Rad Med Oncology 2019 NJ.pptx Copyright © 2017 RCI All Rights Reserved. Do Not Duplicate. Work product, information and guidance provided by RCI are subject to the terms and limitations provided at http://www.revenuecycleinc.com/disclaimero Overcoming 2019 Documentation and Coding Hurdles Presented by Ron DiGiaimo, MBA …
Please see additional Important Safety Information on the following pages and full Prescribing Information, including Boxed WARNINGS. Now approved and available POMALYST (pomalidomide) capsules approved to treat Kaposi sarcoma Now approved and available Selected Important Safety Information: Boxed WARNINGS Indications POMALYST® (pomalidomide) is a thalidomide analogue indicated for …
Fairness Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Fairness Lee E. Mortenson To cite this article: Lee E. Mortenson (1994) Fairness, Oncology Issues, 9:3, 2-2, DOI: …
Patient Advocacy and ACCC Initiatives Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Patient Advocacy and ACCC Initiatives To cite this article: (1998) Patient Advocacy and ACCC …
Cancer Program Fundraising Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Cancer Program Fundraising 5 Viewpoints To cite this article: (1996) Cancer Program Fundraising, Oncology …
Patient Advocacy and ACCC Initiatives Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Patient Advocacy and ACCC Initiatives To cite this article: (1998) Patient Advocacy and ACCC …
The interpretation of multigene next-generation sequencing (NGS) tests can be complex, especially when the test report indicates tumoral heterogeneity or subclonal mutations. Actionable genomic alterations may include somatic gene rearrangements, deletions, insertions, fusions, exxon skipping, single nucleotide change, and copy number of variants. Germline pathogenic variants …
ND11-All-Good-Things-Must-Come-to-an-End
Irreparable Harm Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Irreparable Harm Lee E. Mortenson To cite this article: Lee E. Mortenson (1998) Irreparable Harm, Oncology …
SO07-Practice-changing-Progress-from-ASCO-2007
ND09-Action
MJ09-President
This edition of Oncology Issues offers some great real-world examples of patient-centric cancer care.
Irreparable Harm Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Irreparable Harm Lee E. Mortenson To cite this article: Lee E. Mortenson (1998) Irreparable Harm, Oncology …
Thank you for your interest in ICLIO Grand Rounds, a personalized learning initiative conducted by the Institute for Clinical Immuno-Oncology (ICLIO), an institute of the Association of Community Cancer Centers (ACCC). ICLIO Grand Rounds will provide evidence-based information on the latest developments in the use of cancer immunotherapy and effective management of associated immune-related …
Dropping Your Pants for Full Coverage Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Dropping Your Pants for Full Coverage Lee E. Mortenson To cite this article: Lee E. Mortenson …
iQueue for Infusion Centers looks at the big picture – your resource availability, staff schedules, operating hours, appointment history and hundreds of other parameters. Set yourself up for a smooth flow with templates engineered to minimize delays by level-loading the day. Your resources are fully utilized, patients spend less time in the waiting room, and …
14 accc-cancer.org | Vol. 37, No. 6, 2022 | OI Approved Drugs • On Sept. 16, the U.S. Food and Drug Administration (FDA) approved Aponvie™ (aprepitant) (Heron Therapeutics, herontx.com/) for the prevention of postoperative nausea and vomiting in adults. • On Aug. 11, the FDA granted accelerated approval to Enhertu® (fam-trastuzumab deruxtecan-nxki) (Daiichi Sankyo, Inc., …
SO12-Creating-a-Circle-of-Care
JF02-Videoconferencing-In-Your-Practice